Award
National Cancer Institute 5R01CA278100-04
Evaluating unique aspects of quiescent ovarian cancer cell biology for therapeutic targets
Recipient
Magee-Women's Research Institute and Foundation
Award Amount
$435,361.00
Ceiling
$435,361.00
Awarded
June 23, 2026
Identifier
5R01CA278100-04
The project investigates the biology of quiescent ovarian cancer cells to identify therapeutic targets that can prevent or treat chemotherapy-resistant ovarian cancer, potentially improving patient outcomes.
Description
This research project aims to define regulators of ovarian cancer cell quiescence, providing novel therapeutic targets to improve patient outcomes by overcoming chemotherapy resistance.